ATE866T1 - IMMUNE GERMINAL GLOBULIN (ISG) PREPARATIONS AND PROCESSES FOR THEIR MANUFACTURE. - Google Patents

IMMUNE GERMINAL GLOBULIN (ISG) PREPARATIONS AND PROCESSES FOR THEIR MANUFACTURE.

Info

Publication number
ATE866T1
ATE866T1 AT79103152T AT79103152T ATE866T1 AT E866 T1 ATE866 T1 AT E866T1 AT 79103152 T AT79103152 T AT 79103152T AT 79103152 T AT79103152 T AT 79103152T AT E866 T1 ATE866 T1 AT E866T1
Authority
AT
Austria
Prior art keywords
globulin
immune
isg
germinal
preparations
Prior art date
Application number
AT79103152T
Other languages
German (de)
Inventor
John L. Lundblad
Willis L. Warner
Peter M. Fernandes
Original Assignee
Cutter Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25517325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE866(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Laboratories, Inc. filed Critical Cutter Laboratories, Inc.
Application granted granted Critical
Publication of ATE866T1 publication Critical patent/ATE866T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Composition comprising an aqueous solution of immune serum globulin and maltose, the amount of maltose being sufficient to inhibit "shedding" of the globulin with time.
AT79103152T 1978-12-18 1979-08-27 IMMUNE GERMINAL GLOBULIN (ISG) PREPARATIONS AND PROCESSES FOR THEIR MANUFACTURE. ATE866T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/970,686 US4186192A (en) 1978-12-18 1978-12-18 Stabilized immune serum globulin
EP79103152A EP0012156B1 (en) 1978-12-18 1979-08-27 Immune serum globulin preparations and method to produce them

Publications (1)

Publication Number Publication Date
ATE866T1 true ATE866T1 (en) 1982-05-15

Family

ID=25517325

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79103152T ATE866T1 (en) 1978-12-18 1979-08-27 IMMUNE GERMINAL GLOBULIN (ISG) PREPARATIONS AND PROCESSES FOR THEIR MANUFACTURE.

Country Status (7)

Country Link
US (1) US4186192A (en)
EP (1) EP0012156B1 (en)
JP (1) JPS5583711A (en)
AT (1) ATE866T1 (en)
CA (1) CA1117417A (en)
DE (1) DE2962569D1 (en)
MX (1) MX6015E (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
US4617379A (en) * 1983-06-14 1986-10-14 Miles Laboratories, Inc. High titer cytomegalovirus immune serum globulin
SE456136B (en) * 1985-06-17 1988-09-12 Oncholab Ab PROCEDURE FOR THE PREPARATION OF A LIPOPHILIC BIOLOGY ACTIVE SUBSTANCE BASED BEARING BASIS OF RECONSTITUTED LDL (Layer Density Lipoprotein)
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717564A (en) * 1985-11-07 1988-01-05 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4659563A (en) * 1986-01-27 1987-04-21 Miles Laboratories, Inc. High titer anti-respiratory syncytial virus intravenous immune globulin
US4911910A (en) * 1986-11-25 1990-03-27 Biotech Research Labs, Inc. Purified equine immunologlobulins and method of use thereof
US5237054A (en) * 1987-02-20 1993-08-17 Akzo Pharma Stabilized aqueous composition containing antibodies
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
EP0417193B1 (en) * 1988-05-27 1993-08-04 Centocor, Inc. Freeze-dried formulation for antibody products
US5221616A (en) * 1988-07-15 1993-06-22 Quidel Corporation Prevention of spontaneous complement activation in mammalian biological fluids
DE4001451A1 (en) * 1990-01-19 1991-08-01 Octapharma Ag STABLE INJECTABLE SOLUTIONS OF FACTOR VIII AND FACTOR IX
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
JPH04112544U (en) * 1990-08-31 1992-09-30 三洋電機株式会社 waterproof phone
DE4344824C1 (en) * 1993-12-28 1995-08-31 Immuno Ag Highly concentrated immunoglobulin preparation and process for its preparation
DE4424935C1 (en) * 1994-07-14 1996-03-21 Immuno Ag Human virus-safe monomeric immunoglobulin A and process for its preparation
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
WO2003068260A1 (en) * 2002-02-14 2003-08-21 Chugai Seiyaku Kabushiki Kaisha Antibody-containing solution pharmaceuticals
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI489994B (en) 2008-03-17 2015-07-01 Baxter Healthcare Sa Combination and method for subcutaneous administration of immunoglobulin and hyaluronic acid
HRP20160530T1 (en) 2009-09-17 2016-07-29 Baxalta Incorporated STABLE CO-FORMULATION OF HYALURONIDASE AND IMMUNOGLOBULIN AND THE METHODS OF ITS USE
CA2788863C (en) 2010-02-04 2020-07-07 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
MX388043B (en) 2014-12-03 2025-03-19 Csl Behring Ag PHARMACEUTICAL PRODUCT WITH INCREMENTED STABILITY THAT INCLUDES IMMUNOGLOBULINS.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB550224A (en) * 1940-08-01 1942-12-30 Lederle Lab Inc Improvements in the preservation of dried blood grouping serum
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
US4089944A (en) * 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
DE2653534C2 (en) * 1975-12-22 1986-08-28 Baxter Travenol Laboratories, Inc., Deerfield, Ill. Solid antihemophil factor preparation and process for its manufacture
JPS5347515A (en) * 1976-10-13 1978-04-28 Green Cross Corp:The Gamma-globulin pharmaceutical preparation for intravenous injection
JPS5420124A (en) * 1977-07-14 1979-02-15 Green Cross Corp:The Preparation of gamma-globulin intravenous injection

Also Published As

Publication number Publication date
EP0012156B1 (en) 1982-04-21
CA1117417A (en) 1982-02-02
US4186192A (en) 1980-01-29
JPH0232261B2 (en) 1990-07-19
EP0012156A1 (en) 1980-06-25
JPS5583711A (en) 1980-06-24
MX6015E (en) 1984-09-24
DE2962569D1 (en) 1982-06-03

Similar Documents

Publication Publication Date Title
ATE866T1 (en) IMMUNE GERMINAL GLOBULIN (ISG) PREPARATIONS AND PROCESSES FOR THEIR MANUFACTURE.
CH393349A (en) Process for the preparation of pyrazolo- (1 ', 5': 3,2) -quinazolones
GB2032437B (en) Method for the preparation of an immune globulin solution suitable for intravenous use
ATE125T1 (en) PROCESS FOR THE PREPARATION OF N-AZOLYLMETHYL-SUBSTITUTED HALOGENACETANILIDES.
ATE3411T1 (en) PROCESS FOR THE PREPARATION OF 2,6DIALKYLCYCLOHEXYLAMINES.
IT7926729A0 (en) PROCEDURE FOR THE PREPARATION OF CYANAZO DYES.
PT70398A (en) PROCESS FOR THE PREPARATION OF 1,2,3-THIADIAZOL-5-YL-UREA SUBSTANCES
DD132664A5 (en) PROCESS FOR THE PREPARATION OF 1,2,4-TRIAZOL- (5) -YL (THIO) PHOSPHATE
DD136832A5 (en) PROCESS FOR THE PREPARATION OF 1,2-DICHLORAETHANE
NL7701695A (en) PROCESS FOR THE PREPARATION OF 2,2-DIMETHYL- -3- (2'.2'-DICHLORVINYL) CYCLOPROPANE-1-CARBONIC ACID.
AT344885B (en) PROCESS FOR THE PREPARATION OF 18-ARABINOSYL-2-N-BUTYL-3,7,11,15,19,21,23,25,27,37-DEKAHYDROXY-4,16,32,34,36-PENTAMETHYL-TETRACONTA- 16,32-DIEN-35-O-LACTONE-40-GUANIDINIUM SULPHATE (DEBRYCIN) CONTAINING PHARMACEUTICAL PREPARATIONS
DD134769A1 (en) PROCESS FOR THE PREPARATION OF 3-OXO-OESTRA-4,9,11-TRIENES
ATE1239T1 (en) PROCESS FOR THE PREPARATION OF 4-AMINO-5-CHLORO-1-PHENYL-PYRIDAZONE-(6).
FI803305A7 (en) Process for the preparation of novel sulfonic acid cycloalkylamides and their use as micromicrobicidal agents.
ATE17712T1 (en) PROCESS FOR THE PREPARATION OF GAMMACHLORACETETTIES|URECHLORIDE.
RO76177A (en) PROCEDURE FOR THE PREPARATION OF OCTAHYDRO-INDOLO-2,3-A / CHINOLISINE-1,1-DISUBSTITUTE
FI803038A7 (en) Preparation of 2,5-diketogluconic acid.
PT70497A (en) PROCESS FOR THE PREPARATION OF 5-MERCAPTO-1,2,3-TRIAZOLENE
PT70178A (en) PROCESS FOR THE PREPARATION OF 1,2,3-THIADIAZOL-5-YL-UREA SUBSTANCES
DE2961506D1 (en) N-cyclohexyl-n-methoxy-acetoacetamide, process for its preparation and its use to prepare o-methyl-n-cyclohexyl-2,5-dimethyl-furane-3-hydroxamic acid
DD128359A5 (en) PROCESS FOR THE PREPARATION OF 5,6-DEHYDROPENICILLINES
DD132497A1 (en) PROCESS FOR THE PREPARATION OF NEW GONA-4,9 (10) -EDIENES
DD132347A5 (en) PROCESS FOR THE PREPARATION OF 17-ACETALES OF 3-ALKOXY-OESTRA-2,5 (10) -DI-17-ONEN
DD132870A5 (en) PROCESS FOR THE PREPARATION OF 2,3-DICHLOR-4- (2-THENOYL) -PHENOXY-ACIDIC ACID
JPS5735932A (en) Emulsifier composition

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time